AzTrials
AzTrials

CataractEP3CNCT02253017

Evaluation of Therapeutic Strategies in Pediatric Cataract Surgery

An observational study of Cataract, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The purpose of this observational study is to assess the therapeutic strategies in the treatment of pediatric cataracts. Read more about this study

Who is it for?
Ages 0 to 17 years
Conditions the study is for
Cataract
What is being tested?
Children operated on for cataract
How many people
0 participants
Where
1 siteFrance
Study dates
Sep 2014to Dec 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: ophthalmology department, Necker hospital.

Who may be able to join

  • Child cataract surgery from 1 September 2014 in the Department of Ophthalmology, University Hospital Necker-Enfants Malades
  • Children aged between 0 and 17 years
  • Child with unilateral or bilateral cataract

Who cannot join

  • Child with bilateral cataract, one eye having previously been operated in another center.
  • Children whose parents have notified the doctor their refusal of data collection

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hospital Necker - Enfants Malades (Assistance Publique-Hôpitaux de Paris)

    Paris, 75015

Other trials in France

About this study

Official title: Assessment Practices Registry in Congenital Cataract Surgery and Infantile

The purpose of this observational study is to assess the therapeutic strategies in the treatment of pediatric cataracts.

Read the detailed description

Technical progress and recently described potential issues have recently challenged the surgical treatment of pediatric cataracts. Many questions remain unsolved: primary vs secondary implantation, nature of the implant used. The aim of this study is to establish a systematic prospective register of all cataracts operated on in a tertiary pediatric centre in order to help answering these questions.

Conditions
Cataract
Being tested
Children operated on for cataract
Keywords
Therapeutic strategies, Pediatrics, Cataract, Surgery, Intra-ocular lens
Medical subject headings
Cataract

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Children operated on for cataractOther

    Compilation of results of monitoring of children aged 8 to 10 months, 3 years, 5 years, 8 years

Study groups in NCT02253017
Study groupRoleWhat they receive
Children operated on for cataractNot described
Receives: Other: Children operated on for cataract

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment practices in Pediatric Cataract Surgery.

    • Rating of efficacy of surgery depending on the implementation or not of a primary location
    • Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal)
    • Evaluation of effectiveness of surgery based on age (<8 weeks of age for unilateral surgery and <11 weeks of life for bilateral surgeries)
    • To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary

    Measured: 8-10 months,

  2. Assessment practices in Pediatric Cataract Surgery.

    • Rating of efficacy of surgery depending on the implementation or not of a primary location
    • Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal)
    • Evaluation of effectiveness of surgery based on age (<8 weeks of age for unilateral surgery and <11 weeks of life for bilateral surgeries)
    • To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary

    Measured: 3 years

  3. Assessment practices in Pediatric Cataract Surgery.

    • Rating of efficacy of surgery depending on the implementation or not of a primary location
    • Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal)
    • Evaluation of effectiveness of surgery based on age (<8 weeks of age for unilateral surgery and <11 weeks of life for bilateral surgeries)
    • To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary

    Measured: 5 years

  4. Assessment practices in Pediatric Cataract Surgery.

    • Rating of efficacy of surgery depending on the implementation or not of a primary location
    • Evaluate the effectiveness of the implementation based on the type of implant (monofocal or multifocal)
    • Evaluation of effectiveness of surgery based on age (<8 weeks of age for unilateral surgery and <11 weeks of life for bilateral surgeries)
    • To assess the frequency of adverse events, particularly glaucoma depending on the occurrence or non-implementation of a primary

    Measured: 8 years (or 6 months after surgery if the child is carried out after 8 years )

Secondary outcomes (13)
  1. Type of surgery and surgical procedures

    Measured: 8-10 months

  2. Type of surgery and surgical procedures

    Measured: 3 years

  3. Type of surgery and surgical procedures

    Measured: 5 years

  4. Type of surgery and surgical procedures

    8 years (or 6 months after surgery if the child is carried out after 8 years).

    Measured: 8 years (or 6 months after surgery if the child is carried out after 8 years).

  5. Type of implant

    Measured: 8-10 months

  6. Type of implant

    Measured: 3 years

  7. Type of implant

    Measured: 5 years

  8. Type of implant

    Measured: 8 years (or 6 months after surgery if the child is carried out after 8 years).

  9. Age at implantation

    Measured: 8-10 months,

  10. Age at implantation

    Measured: 3 years,

  11. Age at implantation

    Measured: 5 years

  12. Age at implantation

    Measured: 8 years (or 6 months after surgery if the child is carried out after 8 years).

  13. Distance visual acuity

    Measured: age of 8 years and 6 months after surgery if the child is carried out after the age of 8.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2014 (estimated)
  2. Study startSep 2014 (estimated)
  3. Primary completionDec 2015 (estimated)
  4. Study completionDec 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02253017
Sponsor's protocol ID
2014-06-13
Acronym
EP3C
Status last verified
Sep 2025
First submitted
26 Sep 2014
Last updated
20 Nov 2025
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cataract, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 20 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment practices in Pediatric Cataract Surgery. (time frame: 8-10 months,). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Nov 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in